1. Phase I Studies of Acebilustat: Pharmacokinetics, Pharmacodynamics, Food Effect, and CYP3A Induction. Issue 1 (28th October 2016) Authors: Elborn, JS; Bhatt, L; Grosswald, R; Ahuja, S; Springman, EB Journal: Clinical and translational science Issue: Volume 10:Issue 1(2017) Page Start: 20 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Phase I Studies of Acebilustat: Biomarker Response and Safety in Patients with Cystic Fibrosis. Issue 1 (2nd November 2016) Authors: Elborn, JS; Horsley, A; MacGregor, G; Bilton, D; Grosswald, R; Ahuja, S; Springman, EB Journal: Clinical and translational science Issue: Volume 10:Issue 1(2017) Page Start: 28 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗